Novo Nordisk close to spinning out IT business; AMRI recruits a new VP;

> Novo Nordisk ($NVO) is in line for up to $335 million as it prepares to spin out its IT business into a standalone contractor. Story

> CROS NT has expanded its agreement with eClinical outfit Datatrak, deepening its relationship with the company's technology for trial management, data capture and randomization. More

> AMRI ($AMRI) has recruited a new vice president of international sales, appointing former Teva ($TEVA) exec Christopher Conway. Item

Suggested Articles

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.

After three full business days in the position, an abrupt about-face has LabCorp Diagnostics’ CEO John Ratliff heading for the exit.

The initiative will see Evotec mine a kidney biobank for new renal therapy targets before the joint venture out-licenses resulting assets to Vifor.